BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 18673201)

  • 1. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.
    Deane R; Sagare A; Zlokovic BV
    Curr Pharm Des; 2008; 14(16):1601-5. PubMed ID: 18673201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
    Deane R; Bell RD; Sagare A; Zlokovic BV
    CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
    Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U
    Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.
    Jeynes B; Provias J
    Curr Alzheimer Res; 2008 Oct; 5(5):432-7. PubMed ID: 18855584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
    Zhu D; Su Y; Fu B; Xu H
    Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
    Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
    Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model.
    Nazer B; Hong S; Selkoe DJ
    Neurobiol Dis; 2008 Apr; 30(1):94-102. PubMed ID: 18289866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of amyloid-beta by circulating lipoprotein receptors.
    Sagare A; Deane R; Bell RD; Johnson B; Hamm K; Pendu R; Marky A; Lenting PJ; Wu Z; Zarcone T; Goate A; Mayo K; Perlmutter D; Coma M; Zhong Z; Zlokovic BV
    Nat Med; 2007 Sep; 13(9):1029-31. PubMed ID: 17694066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
    Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
    Deane R; Zlokovic BV
    Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Blood-Brain Barrier in Alzheimer's Disease.
    Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
    J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.
    Jaeger LB; Dohgu S; Sultana R; Lynch JL; Owen JB; Erickson MA; Shah GN; Price TO; Fleegal-Demotta MA; Butterfield DA; Banks WA
    Brain Behav Immun; 2009 May; 23(4):507-17. PubMed ID: 19486646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
    Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
    Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia.
    Yan FL; Zheng Y; Zhao FD
    Acta Neuropathol; 2008 Nov; 116(5):529-35. PubMed ID: 18830615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.
    Erickson MA; Hartvigson PE; Morofuji Y; Owen JB; Butterfield DA; Banks WA
    J Neuroinflammation; 2012 Jun; 9():150. PubMed ID: 22747709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
    Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.